Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Mar;48(3):774-9.
doi: 10.1128/AAC.48.3.774-779.2004.

Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms

Affiliations
Comparative Study

Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms

Hiroshi Hamamoto et al. Antimicrob Agents Chemother. 2004 Mar.

Abstract

The injection of bacteria (Staphylococcus aureus, Stenotrophomonas maltophilia) or true fungi (Candida albicans, Candida tropicalis) that are pathogenic to humans into the silkworm hemolymph leads to death of the larvae within 2 days. Antibiotics used for clinical purposes have therapeutic effects on silkworms infected with these pathogens. The 50% effective doses obtained by injection into the silkworm hemolymph are consistent with those reported for mice. Injection of vancomycin and kanamycin into the silkworm hemolymph was effective, but oral administration was not. Chloramphenicol, which is effective by oral administration, appeared in the silkworm hemolymph soon after injection into the midgut, whereas vancomycin did not. Isolated midgut membranes were impermeable to vancomycin. Thus, the ineffectiveness of oral administration of vancomycin to silkworms is due to a lack of intestinal absorption.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Therapeutic effects of antibiotics in silkworms infected with S. aureus (A) or S. maltophilia (B). Data are representative of one of two identical experiments.
FIG. 2.
FIG. 2.
Therapeutic effects of antifungal drugs in silkworms infected with the true fungus C. tropicalis (A) or C. albicans (B). Data are representative of one of two identical experiments.
FIG. 3.
FIG. 3.
Therapeutic effects of antibiotics administered i.m. (A) or p.o. (B) on silkworms infected with S. aureus.
FIG. 4.
FIG. 4.
Transport of chloramphenicol and vancomycin from the midgut to the hemolymph in living silkworms. All data points are averages of duplicate samples.
FIG. 5.
FIG. 5.
Transport of antibiotics from isolated midguts. (A) Time course of transport with 1 mM chloramphenicol or vancomycin. (B) Transport of chloramphenicol and vancomycin at various concentrations for 30 min. All data points are averages of duplicate samples.

References

    1. Akimitsu, N., H. Hamamoto, R. Inoue, M. Shoji, A. Akamine, K. Takemori, N. Hamasaki, and K. Sekimizu. 1999. Increase in resistance of methicillin-resistant Staphylococcus aureus to beta-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals. Antimicrob. Agents Chemother. 43:3042-3043. - PMC - PubMed
    1. Ates, O., A. Gursoy, H. Altintas, G. Otuk, and S. Birteksoz. 2003. Synthesis and antimicrobial activity of {2-[2-(N,N-disubstituted thiocarbamoyl-sulfanyl)-acylamino] thiazol-4-yl} acetic acid ethyl esters. Arch. Pharm. (Weinheim) 336:39-46. - PubMed
    1. Bernal, A., and D. A. Kimbrell. 2000. Drosophila Thor participates in host immune defense and connects a translational regulator with innate immunity. Proc. Natl. Acad. Sci. USA 97:6019-6024. - PMC - PubMed
    1. Ford, C. W., J. C. Hamel, D. M. Wilson, J. K. Moerman, D. Stapert, R. J. Yancey, Jr., D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections. Antimicrob. Agents Chemother. 40:1508-1513. - PMC - PubMed
    1. Ikeda, F., Y. Wakai, S. Matsumoto, K. Maki, E. Watabe, S. Tawara, T. Goto, Y. Watanabe, F. Matsumoto, and S. Kuwahara. 2000. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis. Antimicrob. Agents Chemother. 44:614-618. - PMC - PubMed

Publication types

MeSH terms

Substances